Literature DB >> 32199881

Carcinogenesis of Pancreatic Ductal Adenocarcinoma.

Peter Storz1, Howard C Crawford2.   

Abstract

Although the estimated time for development of pancreatic ductal adenocarcinoma (PDA) is more than 20 years, PDAs are usually detected at late, metastatic stages. PDAs develop from duct-like cells through a multistep carcinogenesis process, from low-grade dysplastic lesions to carcinoma in situ and eventually to metastatic disease. This process involves gradual acquisition of mutations in oncogenes and tumor suppressor genes, as well as changes in the pancreatic environment from a pro-inflammatory microenvironment that favors the development of early lesions, to a desmoplastic tumor microenvironment that is highly fibrotic and immune suppressive. This review discusses our current understanding of how PDA originates.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Desmoplastic Reaction; Microenvironment; Pancreatic Ductal Adenocarcinoma; Pancreatic Intraepithelial Neoplasia

Mesh:

Substances:

Year:  2020        PMID: 32199881      PMCID: PMC7282937          DOI: 10.1053/j.gastro.2020.02.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  132 in total

1.  Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia.

Authors:  Kyoung Eun Lee; Michelle Spata; Lauren J Bayne; Elizabeth L Buza; Amy C Durham; David Allman; Robert H Vonderheide; M Celeste Simon
Journal:  Cancer Discov       Date:  2015-12-29       Impact factor: 39.397

2.  Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival.

Authors:  Berna C Özdemir; Tsvetelina Pentcheva-Hoang; Julienne L Carstens; Xiaofeng Zheng; Chia-Chin Wu; Tyler R Simpson; Hanane Laklai; Hikaru Sugimoto; Christoph Kahlert; Sergey V Novitskiy; Ana De Jesus-Acosta; Padmanee Sharma; Pedram Heidari; Umar Mahmood; Lynda Chin; Harold L Moses; Valerie M Weaver; Anirban Maitra; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Cancer Cell       Date:  2014-05-22       Impact factor: 31.743

3.  Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

Authors:  Akihisa Fukuda; Sam C Wang; John P Morris; Alexandra E Folias; Angela Liou; Grace E Kim; Shizuo Akira; Kenneth M Boucher; Matthew A Firpo; Sean J Mulvihill; Matthias Hebrok
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

4.  Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer.

Authors:  Tomohisa Yamamoto; Hiroaki Yanagimoto; Sohei Satoi; Hideyoshi Toyokawa; Satoshi Hirooka; So Yamaki; Rintaro Yui; Jun Yamao; Songtae Kim; A-Hon Kwon
Journal:  Pancreas       Date:  2012-04       Impact factor: 3.327

5.  The acinar regulator Gata6 suppresses KrasG12V-driven pancreatic tumorigenesis in mice.

Authors:  Paola Martinelli; Francesc Madriles; Marta Cañamero; Enrique Carrillo-de Santa Pau; Natalia Del Pozo; Carmen Guerra; Francisco X Real
Journal:  Gut       Date:  2015-01-16       Impact factor: 23.059

6.  PanIN Neuroendocrine Cells Promote Tumorigenesis via Neuronal Cross-talk.

Authors:  Smrita Sinha; Ya-Yuan Fu; Adrien Grimont; Maren Ketcham; Kelly Lafaro; Joseph A Saglimbeni; Gokce Askan; Jennifer M Bailey; Jerry P Melchor; Yi Zhong; Min Geol Joo; Olivera Grbovic-Huezo; In-Hong Yang; Olca Basturk; Lindsey Baker; Young Park; Robert C Kurtz; David Tuveson; Steven D Leach; Pankaj J Pasricha
Journal:  Cancer Res       Date:  2017-04-06       Impact factor: 12.701

7.  CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans.

Authors:  Gregory L Beatty; Elena G Chiorean; Matthew P Fishman; Babak Saboury; Ursina R Teitelbaum; Weijing Sun; Richard D Huhn; Wenru Song; Dongguang Li; Leslie L Sharp; Drew A Torigian; Peter J O'Dwyer; Robert H Vonderheide
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

8.  Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells.

Authors:  K E Richards; A E Zeleniak; M L Fishel; J Wu; L E Littlepage; R Hill
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867

9.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.

Authors:  Cristovão M Sousa; Douglas E Biancur; Xiaoxu Wang; Christopher J Halbrook; Mara H Sherman; Li Zhang; Daniel Kremer; Rosa F Hwang; Agnes K Witkiewicz; Haoqiang Ying; John M Asara; Ronald M Evans; Lewis C Cantley; Costas A Lyssiotis; Alec C Kimmelman
Journal:  Nature       Date:  2016-08-10       Impact factor: 49.962

10.  CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma.

Authors:  Colin W Steele; Saadia A Karim; Joshua D G Leach; Peter Bailey; Rosanna Upstill-Goddard; Loveena Rishi; Mona Foth; Sheila Bryson; Karen McDaid; Zena Wilson; Catherine Eberlein; Juliana B Candido; Mairi Clarke; Colin Nixon; John Connelly; Nigel Jamieson; C Ross Carter; Frances Balkwill; David K Chang; T R Jeffry Evans; Douglas Strathdee; Andrew V Biankin; Robert J B Nibbs; Simon T Barry; Owen J Sansom; Jennifer P Morton
Journal:  Cancer Cell       Date:  2016-06-02       Impact factor: 38.585

View more
  39 in total

Review 1.  The pancreatic cancer genome revisited.

Authors:  Akimasa Hayashi; Jungeui Hong; Christine A Iacobuzio-Donahue
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-04       Impact factor: 46.802

2.  Nuclear factor kappa-B contributes to cigarette smoke tolerance in pancreatic ductal adenocarcinoma through cysteine metabolism.

Authors:  Venugopal Gunda; Yashpal S Chhonker; Nagabhishek Sirpu Natesh; Pratima Raut; Sakthivel Muniyan; Todd A Wyatt; Daryl J Murry; Surinder K Batra; Satyanarayana Rachagani
Journal:  Biomed Pharmacother       Date:  2021-10-19       Impact factor: 6.529

Review 3.  Cellular and molecular mechanisms of plasticity in cancer.

Authors:  Stefan R Torborg; Zhuxuan Li; Jason E Chan; Tuomas Tammela
Journal:  Trends Cancer       Date:  2022-05-23

Review 4.  The Desmoplastic Stroma of Pancreatic Cancer: Multilayered Levels of Heterogeneity, Clinical Significance, and Therapeutic Opportunities.

Authors:  Yohei Masugi
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

5.  Development of Nomograms for Predicting Prognosis of Pancreatic Cancer after Pancreatectomy: A Multicenter Study.

Authors:  So Jeong Yoon; Boram Park; Jaewoo Kwon; Chang-Sup Lim; Yong Chan Shin; Woohyun Jung; Sang Hyun Shin; Jin Seok Heo; In Woong Han
Journal:  Biomedicines       Date:  2022-06-07

Review 6.  Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review.

Authors:  Barbara Kenner; Suresh T Chari; David Kelsen; David S Klimstra; Stephen J Pandol; Michael Rosenthal; Anil K Rustgi; James A Taylor; Adam Yala; Noura Abul-Husn; Dana K Andersen; David Bernstein; Søren Brunak; Marcia Irene Canto; Yonina C Eldar; Elliot K Fishman; Julie Fleshman; Vay Liang W Go; Jane M Holt; Bruce Field; Ann Goldberg; William Hoos; Christine Iacobuzio-Donahue; Debiao Li; Graham Lidgard; Anirban Maitra; Lynn M Matrisian; Sung Poblete; Laura Rothschild; Chris Sander; Lawrence H Schwartz; Uri Shalit; Sudhir Srivastava; Brian Wolpin
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.243

7.  Establishment of a pancreatic cancer animal model using the pancreas-targeted hydrodynamic gene delivery method.

Authors:  Osamu Shibata; Kenya Kamimura; Yuto Tanaka; Kohei Ogawa; Takashi Owaki; Chiyumi Oda; Shinichi Morita; Atsushi Kimura; Hiroyuki Abe; Satoshi Ikarashi; Kazunao Hayashi; Takeshi Yokoo; Shuji Terai
Journal:  Mol Ther Nucleic Acids       Date:  2022-03-28       Impact factor: 10.183

Review 8.  Therapeutic Potential of Targeting Stromal Crosstalk-Mediated Immune Suppression in Pancreatic Cancer.

Authors:  Wenting Du; Marina Pasca di Magliano; Yaqing Zhang
Journal:  Front Oncol       Date:  2021-07-05       Impact factor: 5.738

Review 9.  The Emerging Role of Circ-SHPRH in Cancer.

Authors:  Xinyue Ju; Yan Tang; Rongfeng Qu; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2021-07-13       Impact factor: 4.147

10.  Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults.

Authors:  Christiana Kartsonaki; Yuanjie Pang; Iona Millwood; Ling Yang; Yu Guo; Robin Walters; Jun Lv; Michael Hill; Canqing Yu; Yiping Chen; Xiaofang Chen; Eric O'Neill; Junshi Chen; Ruth C Travis; Robert Clarke; Liming Li; Zhengming Chen; Michael V Holmes
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.